Disappointing news on Breezula/CB-03-01
    2/8/2019

    At a glance
    In this general discussion post, the primary subjects mentioned are
    ๐Ÿ’ง Breezula (topical) 2x daily
    ๐Ÿ’Š Finasteride (oral) 1x daily
    ๐Ÿ’ง Minoxidil (topical) 1x daily
    ๐Ÿ’ง Nizoral (topical) 2x weekly
    ๐Ÿ’ง dermarolling (topical) 1x weekly
    the tone is ๐Ÿ˜ neutral with statistically significant improvement results.

    Other terms

    The conversation discusses disappointment over only receiving a financial report from Cassiopea instead of trial results for Breezula/CB-03-01, a hair loss treatment. However, there is optimism as the company is advancing Breezula into Phase III trials for men, starting trials for women, and submitting an NDA for their acne product, Winlevi.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 192 results

    Related Research

    6 / 10 results